PHARMACEUTICAL COMPOSITION, INCLUDING AN AMIDA DERIVATIVE, INHIBITING CANCER CELL GROWTH, AND A LUBRICANT, NOT A METAL SALT

摘要

1. A pharmaceutical composition comprising a substance of formula (I) or a pharmaceutically acceptable salt thereof and a non-metal lubricant: 2. The pharmaceutical composition according to claim 1, wherein the claimed non-metal lubricant is selected from the group consisting of fatty acid esters, fatty acids, fatty alcohols, oils, fumaric acid, polyethylene glycols (PEGs), talc and mixtures thereof. 3. The pharmaceutical composition of claim 2, wherein the claimed non-metal salt lubricant is selected from the group consisting of glyceryl behenate, glyceryl palmitostearate, glyceryl monostearate, glyceryl trimyristate, glyceryl tristearate, sucrose and fatty acid ester, palmitic acid, palmitic acid, palmitic acid, palmitic acid, palmitic acid acid, stearyl alcohol, hydrogenated castor oil, mineral oil, hydrogenated vegetable oil, fumaric acid; PEG 4000, PEG 6000; polytetrafluoroethylene; starch, talc and mixtures thereof. 4. The pharmaceutical composition of claim 3, wherein the claimed non-metal lubricant is a sucrose and fatty acid ester or hydrogenated vegetable oil. The pharmaceutical composition according to claim 1, wherein the claimed substance of formula (I) is contained in an amount in the range from 0.1 mg to 100 mg per 1 dosage unit of the composition. The pharmaceutical composition of claim 1, wherein the claimed non-metal lubricant is contained in an amount in the range of 0.1 to 100 parts by weight based on 1 part by weight of the compound of formula (I). 7. The pharmaceutical composition according to claim 1, further comprising a pharmaceutically acceptable additive selected from the group consisting of a diluent,